Harvard Business Review

MARCH 1, 2012

It's a private, independent company in the Chicago area that handles biopharma production for a number of partners. Hospira began life when Abbott Laboratories spun off its production division, and it is now the world leader in the production of injectable pharmaceuticals. For example, in biotechnology, a field in which the U.S.

Contract Manufacturing 9

Contract Manufacturing Offshoring Supply Chain Biotechnology 9

Harvard Business Review

MAY 1, 2014

I learned this while leading a turnaround of NPS Pharmaceuticals , a biotechnology company that now specializes in creating treatments for rare diseases. In the process, I came up with six rules that could also help others change their cultures. To save the 20-year-old company, I had to get it operating like a start-up.

Company 9

Company Pharmaceuticals Biotechnology Short-term 9

Harvard Business Review

FEBRUARY 17, 2011

The reason for the interest in in part because the industry has suffered from poor returns on investment over the last decade; indeed, some sectors, including biotechnology, report negative aggregate returns. Investing in a specialty hospital or HMO can accelerate the process of demonstrating value.

Marketing 15

Marketing Venture Capitalist Biotechnology IPO 15

Harvard Business Review

OCTOBER 22, 2013

In order to do this, your company needs a process to source radical ideas that can catapult your business to new heights, open up new markets, or bring in completely unfamiliar profit streams. Today, YouTube and Netflix are actively pivoting the entertainment production industry by creating new original online video channels.

Skills 8

Skills Power Six Sigma Disruptive Innovation 8

Harvard Business Review

JULY 16, 2013

Although many boards continue to select new members from their own networks, our research suggests that more are beginning to implement objective processes to select members based on the skills and attributes that boards need to be effective. food, beverage & tobacco, household and personal products); Energy & Utilities (e.g.,

Telecommunications 8

Telecommunications Biotechnology Health Care Real Estate 8

Harvard Business Review

JUNE 16, 2016

The private sector spends three times that , mostly on translational research intended to transform basic discoveries into new products. There is a wide chasm that separates an initial discovery and a viable product idea. Innovating the Innovation Process. Yet the Valley of Death still remains. Killing Ideas Faster.

Technology 8

Technology Venture Capitalist Supply Chain Innovation 8

Harvard Business Review

MAY 10, 2016

As our research has shown us, the core of the problem is not the high number of M&A deals in itself, but rather that too many executives bring insufficient discipline to the evaluation process that fuels these deals — as a result, they often get deals wrong.

Strategy 8

Strategy Company Biotechnology Franchising 8

Harvard Business Review

OCTOBER 23, 2014

Actors in this ecosystem are increasingly working together rather than handing off information or tasks to the next entity in a linear process. That’s why pharmaceutical, biotechnology, and medical device companies need to define their relevance in this new health care ecosystem, and soon. They’re also sharing risk. But not for long.

Health Care 8

Health Care Pharmaceuticals Information Technology Supply Chain 8

Harvard Business Review

SEPTEMBER 14, 2011

Chirotech specializes in biocatalysis and chemocatalysis, two important subspecialties of biotechnology and chemistry that help develop key biological and chemical intermediates needed for the efficient production of medicines. Reliance MediaWorks.

Globalization 10

Globalization Innovation Decentralization Chemicals 10

Harvard Business Review

JUNE 23, 2015

So instead of looking at it as a substitute for existing manufacturing, we should look to new areas where it can exploit its unique capabilities to complement traditional manufacturing processes. In these cases, 3D printing has to compete with scale-driven manufacturing processes and rather efficient logistics operations.

Supply Chain 8

Supply Chain Tacit Knowledge Contract Manufacturing Biotechnology 8

Harvard Business Review

FEBRUARY 3, 2015

As these managers start to concern themselves with broad strategic issues and organizational change processes, lateral relationships with people outside their immediate area become even more critical to the manag­ers’ ability to get things done. Consider why incumbents rarely lead the way in new products and services.

How To 8

How To Diversity Letter Learning-by-Doing 8

Harvard Business Review

APRIL 19, 2016

In virtually every advanced field, whether it’s information technology, biotechnology, agriculture, or renewable energy, America holds a leading position. So for companies looking to create revolutionary products, identifying and accessing cutting edge, exploratory research is a key competitive advantage. vincent tsui FOR HBR.

Innovation 8

Innovation Company Competitive Advantage Venture Funding 8

Harvard Business Review

MAY 28, 2013

chemicals, metals and mining, paper and forest products), made out worst, scoring poorly on "firing" and "leveraging diversity," and not much better on "assessing talent" and "developing talent.". food, beverage & tobacco, household and personal products); Energy & Utilities (e.g., chemicals, metals & mining, paper & forest products).

Talent Management 8

Talent Management Company Telecommunications Management 8

Harvard Business Review

MARCH 5, 2012

A major reason for the decline in manufacturing employment in recent decades is the huge increases in the productivity of American factories. With those productivity gains likely to continue (a good thing), it is hard to imagine how manufacturing could ever return to its glory days, when it employed about a quarter of the U.S.

Health Care 9

Health Care Biotechnology Industry Policies 9

Harvard Business Review

MARCH 30, 2017

Received wisdom is that the more diverse the teams in terms of age, ethnicity, and gender, the more creative and productive they are likely to be. Cognitive diversity has been defined as differences in perspective or information processing styles. We worked with a startup biotechnology company.

Diversity 8

Diversity Team Biotechnology Execution 8

Harvard Business Review

SEPTEMBER 11, 2014

That’s because there are two primary types of uncertainty — demand uncertainty (will customers buy your product?) In our new book, The Innovator’s Method , we show how managers can adapt these tools, in an end-to-end process, for managing innovation. Although uncertainty is accelerating, it isn’t affecting all industries the same way.

Uncertainty 22

Uncertainty Industry Bottom-up Technology 22

Harvard Business Review

JUNE 12, 2012

trillion in government support for seven "strategic emerging industries," including alternative energy, biotechnology, next-gen IT, high-end manufacturing equipment, and advanced materials. A decade from now we may look back at China's 12th Five-Year Plan as the seminal document of the early 21st century. It pledges $1.5

First-mover Advantage 9

First-mover Advantage GDP Technology Biotechnology 9

Harvard Business Review

MAY 15, 2015

Works like these are reflections of the American story, which has always experienced tension between its narrative of meritocratic social mobility, its long history of racial inequality, and the boom-bust economic cycles that have allowed rapacious monopolists to manipulate the political process with impunity.

Class 8

Class Open-book Politics Biotechnology 8

Harvard Business Review

NOVEMBER 9, 2016

New Zealand is the world’s largest exporter of dairy products. Intense biotechnology research and development activities at some of the country’s universities (and their research farms) have raised the complexity and level of the industry’s outputs. Expand into more products and industries.

Cooper 14

Cooper Long-term Industry Health Care 14

Harvard Business Review

AUGUST 23, 2016

” Directors of both political views rate their boards similarly on processes, dynamics, and effectiveness as a whole, but differ on the question of compensation. food, beverage & tobacco, household and personal products); Energy & Utilities (e.g., chemicals, metals & mining, paper & forest products).

Politics 8

Politics Committee Telecommunications Diversity 8